Puma Biotechnology, based in Los Angeles, received FDA approval for NERLYNX cancer treatments and presented findings in New York City.

The entities involved

• Puma Biotechnology →

  pharmaceutical company

  Nothing else this week.

• Los Angeles →

  seat of Los Angeles County, and largest city in California, United States

  • Los Angeles City Council voted to allow noncitizen voting in city elections, supported by Angelica Salas.Mon 17:37
  • Cities announce hosting duties for the 2027 Water Polo World Cup and the qualifiers for the LA 2028 Olympics.Mon 17:19
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

• A network focused on cell and gene therapies is expanding to include sites in Northern California, involving the CA Institute for Regenerative Medicine and the FDA.Fri 15:36
• BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.Jun 7
• UroGen Pharma Ltd., headquartered in Princeton, is seeking FDA approval for its products for the U.S. market.Sep 4
• Cronus Pharma LLC, headquartered in East Brunswick, is launching products in the U.S. market and seeking FDA approval.Aug 26
• Fate Therapeutics, based in San Diego, is seeking support for an accelerated regulatory pathway from the FDA.Aug 14